Explore how selective biochemical inhibitors are transforming cancer treatment through precision targeting of molecular pathways while minimizing damage to healthy cells.
Discover how hyperpolarized ¹³C MRI technology is revolutionizing cancer diagnosis by allowing real-time visualization of tumor metabolism.
Exploring the paradigm shift in cancer treatment through metabolic reprogramming, featuring key research from the 2nd International Conference for Cancer Metabolism and Therapy.
Discover how ICL-CCIC-0019, a novel CHKA inhibitor, starves cancer cells by disrupting phosphatidylcholine synthesis and triggering metabolic collapse.
Exploring how engineered tumor microenvironments are transforming cancer research and drug development.